AI Tool Comparison
Recursion vs AliveCor
An objective side-by-side comparison based on global rankings, AI scores, and monthly user data.
Higher ranked
Recursion
HealthcareAI-enabled drug discovery platform.
AI Score72.5 / 100
#271
Global rank
–
Monthly users
VS
AliveCor
HealthcarePersonal ECG devices with AI analysis.
AI Score21.4 / 100
#1206
Global rank
–
Monthly users
Side-by-Side Comparison
| Recursion | AliveCor | |
|---|---|---|
| Category | Healthcare | Healthcare |
| Global Rank | #271 | #1206 |
| AI Score | 72.5/100 | 21.4/100 |
| Monthly Users | – | – |
| Pricing | Contact Sales | Paid |
| Website | recursion.com | alivecor.com |
Pros & Cons
Recursion
- Large pipeline after the Exscientia merger
- Public reporting
- Cash runway into early 2028
- No approved drug yet
- Large net losses against small revenue
- Details come mostly from secondary sources
AliveCor
- Quick 30-second readings
- FDA-cleared six-lead design
- One-time device purchase with an optional membership
- Prices vary by retailer and country
- Not a substitute for a medical evaluation
- Kardia AI features could not be confirmed